DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
Conditions: Tetanus; Diphtheria; Pertussis; Poliomyelitis; Bacterial MeningitisInterventions: Biological: DTaP-IPV/Hib Combined vaccine; Biological: DTaP-IPV vaccine and Hib vaccineSponsor: Sanofi Pasteur, a Sanofi CompanyRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2014 Category: Research Source Type: clinical trials
DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants
Conditions: Tetanus; Diphtheria; Pertussis; Poliomyelitis; Bacterial MeningitisInterventions: Biological: DTaP-IPV/Hib Combined vaccine; Biological: DTaP-IPV vaccine and Hib vaccineSponsors: Sanofi Pasteur, a Sanofi Company; SanofiRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 22, 2014 Category: Research Source Type: clinical trials
Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
Conditions: Diphtheria; Tetanus; Pertussis; Hepatitis B; Haemophilus Influenza Type BIntervention: Sponsor: LG Life SciencesNot yet recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2014 Category: Research Source Type: clinical trials
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; TetanusIntervention: Biological: Infanrix hexa™Sponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Poliomyelitis; Tetanus; Acellular Pertussis; Haemophilus Influenzae Type b; Diphtheria; Hepatitis BIntervention: Biological: Infanrix hexa™Sponsor: GlaxoSmithKlineCompleted - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; TetanusIntervention: Biological: Infanrix hexa™Sponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials
